vimarsana.com

Page 30 - நோர்வே நிறுவனம் ஆஃப் பொது ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covid-19 vaccines by Johnson & Johnson and AstraZeneca should be excluded over potential side effects – Norwegian health experts

Follow RT on The Institute of Public Health in Norway has recommended against the use of the Johnson & Johnson vaccine, adding to a recommendation of permanently avoiding the use of the AstraZeneca Covid-19 jab over side effect fears. In a press release on Monday, the Norwegian Institute of Public Health (NIPH) advised the government against the use of the Johnson & Johnson Covid-19 jab, following guidance from a government-appointed commission. The committee also supported an earlier recommendation by the NIPH not to use the AstraZeneca shot.  “We do not recommend that the vaccines be used in the national vaccination program due to the serious side effects that have been seen,” Lars Vorland, chair of the expert committee, said at a press conference on Monday. 

Norway excludes AstraZeneca from vaccination campaign

Norway excludes AstraZeneca from vaccination campaign ​ By IANS | ​ 6 Views   WHO says surplus AstraZeneca vaccines in rich nations must go to poor countries.. Image Source: IANS News Copenhagen, May 13 : Norway has removed the vaccine against Covid-19 made by AstraZeneca from its inoculation campaign, Prime Minister Erna Solberg said. Solberg said on Wednesday that the decision was based on the advice of a committee of experts and the Norwegian Institute of Public Health (FHI), which recommended excluding the shots made by AstraZeneca and Johnson & Johnson due to the risk of very rare but serious side effects, DPA news agency reported. Norway is also extending its temporary halt on the use of the Johnson & Johnson shot, but has not excluded it from its inoculation campaign for now, Solberg said.

WHO to restart Covid trial to test if three existing drugs can save lives of hospitalised patients

The trial has recruited more than 11 000 participants across 30 countries In the new trial, researchers will test three existing drugs effect on hospitalised Covid patients A new international clinical trial that will test potential Covid-19 therapies is about to start, according to a report by The clinical trial, named Solidarity, is coordinated by the World Health Organization (WHO), who will look at three drugs in particular and their ability to decrease inflammation in Covid patients – an approach, the report notes, that has already shown promise in people hospitalised with the disease. The WHO launched Solidarity in March 2020, but the study centred on antiviral drugs at the time. The trial had enrolled more than 11 000 participants hospitalised with Covid in 30 countries by October 2020, but the leaders of the study found that none of the four drugs tested reduced hospital stay or prevented death.

Norway excludes AstraZeneca from vaccination campaign, says PM Erna Solberg

Norway has removed the vaccine against Covid-19 made by AstraZeneca from its inoculation campaign, Prime Minister Erna Solberg said. Solberg said on Wednesday that the decision was based on the advice of a committee of experts and the Norwegian Institute of Public Health (FHI), which recommended excluding the shots made by AstraZeneca and Johnson & Johnson due to the risk of very rare but serious side effects, DPA news agency reported. Norway is also extending its temporary halt on the use of the Johnson & Johnson shot, but has not excluded it from its inoculation campaign for now, Solberg said. The government is currently looking into offering the Johnson & Johnson vaccine to those willing to receive it.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.